FUNDING
Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.
Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.
Electroducer Reports Major Medical Advance in RX of Heart Valve Disease. Company Raises €3 Mil to Market Its Device in Europe and the USA Commencing...
The Electroducer Sleeve is a device with no equivalent anywhere in the world. It is based on a medical technique called Direct Wire Pacing (DWP®), which was invented by the company’s founder, Dr. Benjamin Faurie, and used for the first time ever in 2011.
Lazurite, Formally Indago Announces $10 Million Financing Close
The company plans to submit its 510(k) premarket notification in late 2021 and expects to receive FDA approval to launch the product in the first half of 2022.
Otolith Labs Announces Closing of $3.3 Million in Seed Financing; Receives “Breakthrough Device” Designation from FDA for Its Prescription Treatment for Vertigo
Investors include Mark Cuban; founders of three companies acquired by large strategics; and four leading ENTs.
Bioretec Completes 7.2 M€ Equity Funding Round
The company focuses to the registration and commercialization of RemeOs™ trauma screws.
NuvoAir Raises $12M in Series A Funding to Improve the Care of Millions Suffering From Lung Conditions
To date, NuvoAir has partnered with providers across the U.S., U.K. and Europe, including Harvard Boston Children's Hospital, New Hampshire's Dartmouth-Hitchcock Medical Center, Royal Brompton Hospital, King's College Hospital in London, as well as pharmaceutical giants Roche, Regeneron and Novartis.
Trudell Medical Group Makes a Strategic Investment in Xenocor
In addition, George Baran, Chair of the Trudell Medical Group will join the Xenocor board.
Veranex Announces Investment From Summit Partners to Form Comprehensive Concept-to-Commercialization Medtech Services Company
As the first phase in building this global entity, Veranex has acquired three complementary solution providers: Ximedica, Quartesian, and Boston Healthcare Associates. By bringing these companies together, Veranex combines the industry’s key pillars of design and engineering, regulatory, clinical, and market access into a single-source solution.
BASMA.com Raises a $3M Series A Round to Scale Up Its Health Tech Platform in the MENA
The UK-based, MENA focused, startup BASMA.com closed $3M in its Series A round of funding led by MEVP with the participation of SOSF, IM capital and returning investors iSME, Cedar Mundi Ventures and IFA capital.